These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29729405)

  • 1. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: A new preeclampsia-like mouse model.
    Yu Q; Qiu Y; Wang X; Tang J; Liu Y; Mei L; Li M; Yang M; Tang L; Gao H; Zhang Z; Xu W; He Q
    Int J Pharm; 2018 Jul; 546(1-2):115-124. PubMed ID: 29729405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy.
    Rengaswamy V; Zimmer D; Süss R; Rössler J
    J Control Release; 2016 Aug; 235():319-327. PubMed ID: 27261335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery.
    Yu J; Jia J; Guo X; Chen R; Feng L
    Placenta; 2017 Oct; 58():1-8. PubMed ID: 28962687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeting liposomes with active recognition of GLUT
    Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
    Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Biological Evaluation of a Novel Integrin α
    Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimer-Stabilized Gold Nanostars as a Multifunctional Theranostic Nanoplatform for CT Imaging, Photothermal Therapy, and Gene Silencing of Tumors.
    Wei P; Chen J; Hu Y; Li X; Wang H; Shen M; Shi X
    Adv Healthc Mater; 2016 Dec; 5(24):3203-3213. PubMed ID: 27901317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
    Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
    Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.
    Chen Y; Wu JJ; Huang L
    Mol Ther; 2010 Apr; 18(4):828-34. PubMed ID: 20068551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vivo gene transfer into the placenta using RGD fiber-mutant adenovirus vector.
    Katayama K; Furuki R; Yokoyama H; Kaneko M; Tachibana M; Yoshida I; Nagase H; Tanaka K; Sakurai F; Mizuguchi H; Nakagawa S; Nakanishi T
    Biomaterials; 2011 Jun; 32(17):4185-93. PubMed ID: 21411139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
    Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
    Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene silencing using RGD-labeled chitosan nanoparticles.
    Han HD; Mangala LS; Lee JW; Shahzad MM; Kim HS; Shen D; Nam EJ; Mora EM; Stone RL; Lu C; Lee SJ; Roh JW; Nick AM; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2010 Aug; 16(15):3910-22. PubMed ID: 20538762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
    Ragelle H; Colombo S; Pourcelle V; Vanvarenberg K; Vandermeulen G; Bouzin C; Marchand-Brynaert J; Feron O; Foged C; Préat V
    J Control Release; 2015 Aug; 211():1-9. PubMed ID: 25989603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
    Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
    Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MALAT-1 is downregulated in preeclampsia and regulates proliferation, apoptosis, migration and invasion of JEG-3 trophoblast cells.
    Chen H; Meng T; Liu X; Sun M; Tong C; Liu J; Wang H; Du J
    Int J Clin Exp Pathol; 2015; 8(10):12718-27. PubMed ID: 26722461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.